| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hernias, Diaphragmatic, Congenital | 26 | 2023 | 324 | 5.170 |
Why?
|
| Extracorporeal Membrane Oxygenation | 18 | 2023 | 581 | 3.020 |
Why?
|
| Infant, Newborn | 69 | 2023 | 8223 | 1.770 |
Why?
|
| Hypertension, Pulmonary | 6 | 2023 | 462 | 1.360 |
Why?
|
| Resuscitation | 6 | 2023 | 223 | 1.120 |
Why?
|
| Oxygen | 6 | 2023 | 754 | 1.090 |
Why?
|
| Urine Specimen Collection | 1 | 2022 | 3 | 0.900 |
Why?
|
| Infant, Extremely Premature | 1 | 2023 | 75 | 0.870 |
Why?
|
| Hernia, Umbilical | 2 | 2020 | 36 | 0.840 |
Why?
|
| Oximetry | 1 | 2023 | 172 | 0.820 |
Why?
|
| Patient Transfer | 2 | 2020 | 137 | 0.790 |
Why?
|
| Specimen Handling | 1 | 2022 | 299 | 0.760 |
Why?
|
| Pulmonary Emphysema | 2 | 2020 | 145 | 0.740 |
Why?
|
| Platelet Transfusion | 3 | 2023 | 156 | 0.730 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 3 | 2020 | 100 | 0.730 |
Why?
|
| Thrombocytopenia | 3 | 2023 | 846 | 0.720 |
Why?
|
| Infant | 27 | 2023 | 13310 | 0.710 |
Why?
|
| Respiration | 1 | 2022 | 447 | 0.710 |
Why?
|
| Catheterization | 5 | 2018 | 410 | 0.710 |
Why?
|
| Ribs | 1 | 2020 | 91 | 0.700 |
Why?
|
| Hand Deformities, Congenital | 1 | 2020 | 87 | 0.690 |
Why?
|
| Lung | 10 | 2023 | 3151 | 0.650 |
Why?
|
| Vasodilator Agents | 2 | 2018 | 219 | 0.650 |
Why?
|
| Infant, Premature | 8 | 2023 | 787 | 0.650 |
Why?
|
| Intensive Care Units, Neonatal | 6 | 2023 | 273 | 0.630 |
Why?
|
| Intubation, Intratracheal | 6 | 2023 | 445 | 0.620 |
Why?
|
| Radiography, Thoracic | 1 | 2020 | 462 | 0.610 |
Why?
|
| Persistent Fetal Circulation Syndrome | 2 | 2016 | 92 | 0.610 |
Why?
|
| Neck | 1 | 2020 | 383 | 0.600 |
Why?
|
| Hypotension | 2 | 2016 | 210 | 0.590 |
Why?
|
| Enterocolitis, Necrotizing | 5 | 2006 | 223 | 0.580 |
Why?
|
| Laryngoscopy | 4 | 2023 | 183 | 0.570 |
Why?
|
| Sildenafil Citrate | 1 | 2016 | 53 | 0.570 |
Why?
|
| Erythrocyte Transfusion | 1 | 2018 | 212 | 0.550 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2016 | 186 | 0.530 |
Why?
|
| Ultrasonography, Prenatal | 8 | 2023 | 830 | 0.520 |
Why?
|
| Pulmonary Alveoli | 1 | 2016 | 208 | 0.510 |
Why?
|
| Ductus Arteriosus, Patent | 4 | 2023 | 137 | 0.510 |
Why?
|
| Retrospective Studies | 36 | 2023 | 37905 | 0.470 |
Why?
|
| Humans | 87 | 2023 | 261506 | 0.460 |
Why?
|
| Respiratory Insufficiency | 2 | 2016 | 330 | 0.450 |
Why?
|
| Prenatal Diagnosis | 5 | 2023 | 590 | 0.450 |
Why?
|
| Pregnancy | 18 | 2023 | 7573 | 0.450 |
Why?
|
| Echocardiography | 5 | 2023 | 1182 | 0.420 |
Why?
|
| Infant, Premature, Diseases | 3 | 2015 | 245 | 0.420 |
Why?
|
| Fetal Diseases | 4 | 2017 | 388 | 0.410 |
Why?
|
| Bronchopulmonary Dysplasia | 3 | 2012 | 161 | 0.390 |
Why?
|
| Delphi Technique | 3 | 2023 | 210 | 0.360 |
Why?
|
| Scrotum | 1 | 2009 | 57 | 0.340 |
Why?
|
| Respiration, Artificial | 2 | 2020 | 577 | 0.330 |
Why?
|
| Natriuretic Peptide, Brain | 3 | 2023 | 343 | 0.330 |
Why?
|
| Blood Transfusion | 3 | 2023 | 583 | 0.330 |
Why?
|
| Biopsy | 1 | 2016 | 3443 | 0.320 |
Why?
|
| Trachea | 5 | 2023 | 259 | 0.300 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2008 | 80 | 0.300 |
Why?
|
| F2-Isoprostanes | 1 | 2007 | 28 | 0.300 |
Why?
|
| Platelet Count | 3 | 2023 | 490 | 0.280 |
Why?
|
| Time-to-Treatment | 2 | 2018 | 292 | 0.280 |
Why?
|
| Liver Diseases | 3 | 2016 | 574 | 0.270 |
Why?
|
| Triticum | 1 | 2005 | 32 | 0.270 |
Why?
|
| Male | 33 | 2023 | 123000 | 0.260 |
Why?
|
| Transportation of Patients | 1 | 2015 | 59 | 0.260 |
Why?
|
| Anemia, Hemolytic | 1 | 2005 | 53 | 0.260 |
Why?
|
| Pulmonary Surfactants | 1 | 2005 | 50 | 0.260 |
Why?
|
| Lenses | 1 | 2004 | 14 | 0.260 |
Why?
|
| Infant, Very Low Birth Weight | 4 | 2008 | 165 | 0.250 |
Why?
|
| Catheterization, Central Venous | 2 | 2021 | 354 | 0.250 |
Why?
|
| Umbilical Arteries | 1 | 2004 | 59 | 0.250 |
Why?
|
| Nasopharynx | 1 | 2005 | 119 | 0.250 |
Why?
|
| Testis | 1 | 2009 | 717 | 0.250 |
Why?
|
| Phytotherapy | 1 | 2005 | 110 | 0.250 |
Why?
|
| High-Frequency Ventilation | 1 | 2004 | 16 | 0.250 |
Why?
|
| Antioxidants | 2 | 2005 | 507 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2005 | 231 | 0.240 |
Why?
|
| Free Radicals | 1 | 2004 | 62 | 0.240 |
Why?
|
| Fetoscopy | 4 | 2023 | 304 | 0.240 |
Why?
|
| Female | 37 | 2023 | 141928 | 0.240 |
Why?
|
| Ostomy | 1 | 2023 | 19 | 0.240 |
Why?
|
| Gentamicins | 1 | 2004 | 90 | 0.240 |
Why?
|
| Blood Gas Analysis | 1 | 2023 | 100 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 14 | 3 | 2020 | 272 | 0.230 |
Why?
|
| Lymphangioma | 1 | 2003 | 36 | 0.230 |
Why?
|
| Dissent and Disputes | 1 | 2003 | 41 | 0.230 |
Why?
|
| Capnography | 1 | 2023 | 15 | 0.230 |
Why?
|
| Biomarkers | 3 | 2023 | 5047 | 0.230 |
Why?
|
| Medical Staff, Hospital | 1 | 2003 | 118 | 0.220 |
Why?
|
| Catheterization, Peripheral | 1 | 2004 | 158 | 0.220 |
Why?
|
| Treatment Refusal | 1 | 2003 | 128 | 0.220 |
Why?
|
| Pediatrics | 2 | 2017 | 1141 | 0.220 |
Why?
|
| Critical Care | 2 | 2015 | 770 | 0.220 |
Why?
|
| Health Information Systems | 1 | 2023 | 34 | 0.210 |
Why?
|
| Professional-Family Relations | 1 | 2003 | 134 | 0.210 |
Why?
|
| Glucocorticoids | 1 | 2006 | 629 | 0.210 |
Why?
|
| Chylothorax | 1 | 2021 | 36 | 0.200 |
Why?
|
| Lymphatic Abnormalities | 1 | 2021 | 29 | 0.200 |
Why?
|
| Intermittent Positive-Pressure Ventilation | 2 | 2020 | 13 | 0.200 |
Why?
|
| Infant, Low Birth Weight | 4 | 2005 | 181 | 0.200 |
Why?
|
| Dexamethasone | 1 | 2006 | 1450 | 0.200 |
Why?
|
| Predictive Value of Tests | 6 | 2019 | 4892 | 0.190 |
Why?
|
| Obstetrics | 1 | 2023 | 221 | 0.190 |
Why?
|
| Quality of Health Care | 1 | 2015 | 621 | 0.190 |
Why?
|
| Chromosome Deletion | 1 | 2005 | 1005 | 0.190 |
Why?
|
| Respiratory System Abnormalities | 1 | 2020 | 39 | 0.180 |
Why?
|
| Positive-Pressure Respiration | 1 | 2020 | 116 | 0.180 |
Why?
|
| Airway Obstruction | 1 | 2023 | 261 | 0.180 |
Why?
|
| Pleural Effusion | 1 | 2021 | 201 | 0.180 |
Why?
|
| Pneumopericardium | 1 | 2019 | 4 | 0.180 |
Why?
|
| Central Venous Catheters | 1 | 2021 | 98 | 0.180 |
Why?
|
| Heart Defects, Congenital | 3 | 2019 | 1697 | 0.180 |
Why?
|
| Laryngeal Neoplasms | 1 | 2003 | 518 | 0.180 |
Why?
|
| Emphysema | 1 | 2020 | 87 | 0.180 |
Why?
|
| Critical Illness | 3 | 2021 | 714 | 0.180 |
Why?
|
| Insulin | 1 | 2005 | 1454 | 0.180 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2018 | 20 | 0.170 |
Why?
|
| Learning | 1 | 2002 | 403 | 0.170 |
Why?
|
| Blood Platelets | 1 | 2023 | 731 | 0.160 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2020 | 199 | 0.160 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2002 | 318 | 0.160 |
Why?
|
| Glutathione | 1 | 2000 | 368 | 0.160 |
Why?
|
| Receptors, Interleukin | 1 | 2018 | 97 | 0.160 |
Why?
|
| Reflex | 1 | 2018 | 68 | 0.160 |
Why?
|
| Alprostadil | 1 | 2018 | 33 | 0.160 |
Why?
|
| Fetal Therapies | 1 | 2018 | 79 | 0.160 |
Why?
|
| Fatal Outcome | 1 | 2020 | 829 | 0.160 |
Why?
|
| Cohort Studies | 8 | 2023 | 9244 | 0.150 |
Why?
|
| Treatment Outcome | 14 | 2023 | 32848 | 0.150 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2018 | 441 | 0.150 |
Why?
|
| Transposition of Great Vessels | 1 | 2018 | 124 | 0.150 |
Why?
|
| Elective Surgical Procedures | 1 | 2018 | 250 | 0.150 |
Why?
|
| Head | 2 | 2015 | 249 | 0.140 |
Why?
|
| Diabetes Mellitus | 1 | 2005 | 1054 | 0.140 |
Why?
|
| Balloon Occlusion | 1 | 2017 | 49 | 0.140 |
Why?
|
| Herniorrhaphy | 1 | 2018 | 169 | 0.140 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 315 | 0.140 |
Why?
|
| Parents | 1 | 2003 | 998 | 0.140 |
Why?
|
| Drug Administration Routes | 1 | 2016 | 60 | 0.140 |
Why?
|
| Prognosis | 4 | 2023 | 21713 | 0.140 |
Why?
|
| Chromosome Aberrations | 3 | 2020 | 1960 | 0.130 |
Why?
|
| Lung Volume Measurements | 3 | 2023 | 88 | 0.130 |
Why?
|
| Prenatal Care | 3 | 2023 | 325 | 0.130 |
Why?
|
| Administration, Intravenous | 1 | 2016 | 249 | 0.130 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2016 | 137 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 3 | 2015 | 2403 | 0.130 |
Why?
|
| Hypothermia, Induced | 1 | 2016 | 170 | 0.130 |
Why?
|
| Infusions, Intravenous | 2 | 2016 | 1382 | 0.130 |
Why?
|
| Hemodynamics | 2 | 2016 | 935 | 0.130 |
Why?
|
| Anemia, Neonatal | 1 | 1994 | 6 | 0.130 |
Why?
|
| Simulation Training | 1 | 2017 | 149 | 0.130 |
Why?
|
| Gastrointestinal Diseases | 1 | 2019 | 589 | 0.120 |
Why?
|
| Peptide Fragments | 2 | 2023 | 1271 | 0.120 |
Why?
|
| Regression Analysis | 1 | 2018 | 1546 | 0.120 |
Why?
|
| Registries | 2 | 2012 | 2170 | 0.120 |
Why?
|
| Thrombosis | 1 | 2021 | 781 | 0.120 |
Why?
|
| Hernia, Diaphragmatic | 3 | 2012 | 121 | 0.120 |
Why?
|
| Abnormalities, Multiple | 1 | 2020 | 998 | 0.120 |
Why?
|
| Birth Weight | 2 | 2023 | 374 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2019 | 7702 | 0.110 |
Why?
|
| Mitochondria | 1 | 2000 | 1282 | 0.110 |
Why?
|
| Vasopressins | 1 | 2013 | 62 | 0.110 |
Why?
|
| Hypertension | 1 | 2023 | 1503 | 0.110 |
Why?
|
| Pneumonectomy | 1 | 2018 | 831 | 0.110 |
Why?
|
| Erythropoietin | 1 | 1994 | 205 | 0.110 |
Why?
|
| Gestational Age | 4 | 2019 | 1069 | 0.110 |
Why?
|
| Quality of Life | 2 | 2018 | 4532 | 0.110 |
Why?
|
| Vasoconstrictor Agents | 1 | 2013 | 151 | 0.110 |
Why?
|
| Administration, Oral | 1 | 2016 | 1544 | 0.110 |
Why?
|
| LIM Domain Proteins | 1 | 2012 | 104 | 0.100 |
Why?
|
| Survivors | 1 | 2018 | 1031 | 0.100 |
Why?
|
| Esophageal Atresia | 1 | 2012 | 48 | 0.100 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2012 | 67 | 0.100 |
Why?
|
| Limb Deformities, Congenital | 1 | 2012 | 112 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 2992 | 0.100 |
Why?
|
| Gene Dosage | 2 | 2012 | 829 | 0.100 |
Why?
|
| Catheters | 1 | 2012 | 126 | 0.100 |
Why?
|
| Genome, Human | 2 | 2011 | 1869 | 0.090 |
Why?
|
| Tertiary Care Centers | 2 | 2018 | 403 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 3472 | 0.090 |
Why?
|
| Cytoskeletal Proteins | 1 | 2012 | 492 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2017 | 6100 | 0.090 |
Why?
|
| Texas | 5 | 2019 | 6311 | 0.090 |
Why?
|
| Child | 8 | 2023 | 29154 | 0.080 |
Why?
|
| Survival Rate | 5 | 2018 | 12221 | 0.080 |
Why?
|
| Humidity | 1 | 2008 | 29 | 0.080 |
Why?
|
| Phenotype | 1 | 2020 | 6295 | 0.080 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 183 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2006 | 6869 | 0.080 |
Why?
|
| Dinoprost | 1 | 2007 | 33 | 0.080 |
Why?
|
| Hot Temperature | 1 | 2008 | 281 | 0.080 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2007 | 95 | 0.070 |
Why?
|
| Chemoprevention | 1 | 2008 | 241 | 0.070 |
Why?
|
| Research Design | 3 | 2023 | 1544 | 0.070 |
Why?
|
| Insulin, Long-Acting | 1 | 2005 | 18 | 0.070 |
Why?
|
| Insulin Glargine | 1 | 2005 | 20 | 0.070 |
Why?
|
| Congenital Abnormalities | 1 | 2009 | 260 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2017 | 1375 | 0.070 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2007 | 542 | 0.070 |
Why?
|
| Platelet Activating Factor | 1 | 2006 | 55 | 0.070 |
Why?
|
| Ohio | 1 | 2015 | 113 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 5687 | 0.070 |
Why?
|
| Umbilical Veins | 1 | 2005 | 115 | 0.070 |
Why?
|
| Cystic Fibrosis | 1 | 2008 | 264 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2012 | 4744 | 0.070 |
Why?
|
| Tachycardia | 1 | 2005 | 70 | 0.060 |
Why?
|
| Effect Modifier, Epidemiologic | 1 | 2004 | 21 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2009 | 399 | 0.060 |
Why?
|
| Gastrointestinal Contents | 1 | 2004 | 12 | 0.060 |
Why?
|
| Short Bowel Syndrome | 1 | 2005 | 60 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 7551 | 0.060 |
Why?
|
| Catheters, Indwelling | 2 | 2021 | 374 | 0.060 |
Why?
|
| Leukomalacia, Periventricular | 1 | 2004 | 13 | 0.060 |
Why?
|
| Indomethacin | 1 | 2004 | 91 | 0.060 |
Why?
|
| Homeopathy | 1 | 2003 | 9 | 0.060 |
Why?
|
| Time Factors | 4 | 2018 | 12926 | 0.060 |
Why?
|
| Airway Management | 1 | 2015 | 102 | 0.060 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2008 | 427 | 0.060 |
Why?
|
| Lymphatic System | 1 | 2003 | 64 | 0.060 |
Why?
|
| Benchmarking | 1 | 2015 | 273 | 0.060 |
Why?
|
| Child, Preschool | 5 | 2018 | 16273 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2004 | 445 | 0.060 |
Why?
|
| Retinopathy of Prematurity | 1 | 2004 | 88 | 0.060 |
Why?
|
| Respiratory Sounds | 1 | 2003 | 95 | 0.060 |
Why?
|
| Primary Prevention | 1 | 2005 | 255 | 0.060 |
Why?
|
| Trisomy | 1 | 2004 | 231 | 0.060 |
Why?
|
| Cardiovascular Agents | 1 | 2004 | 128 | 0.060 |
Why?
|
| Cholestasis | 1 | 2005 | 203 | 0.050 |
Why?
|
| Pneumonia | 2 | 2012 | 751 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2004 | 183 | 0.050 |
Why?
|
| Larynx | 1 | 2003 | 134 | 0.050 |
Why?
|
| Neonatology | 1 | 2002 | 42 | 0.050 |
Why?
|
| Administration, Inhalation | 1 | 2023 | 285 | 0.050 |
Why?
|
| Length of Stay | 2 | 2019 | 1900 | 0.050 |
Why?
|
| Quality Indicators, Health Care | 1 | 2015 | 348 | 0.050 |
Why?
|
| Mosaicism | 1 | 2004 | 272 | 0.050 |
Why?
|
| Enteral Nutrition | 1 | 2004 | 316 | 0.050 |
Why?
|
| ROC Curve | 2 | 2015 | 1183 | 0.050 |
Why?
|
| Octreotide | 1 | 2021 | 118 | 0.050 |
Why?
|
| Stomach | 1 | 2004 | 387 | 0.050 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 4320 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2008 | 1230 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2016 | 6009 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 2508 | 0.050 |
Why?
|
| Diaphragm | 1 | 2021 | 181 | 0.050 |
Why?
|
| Thorax | 1 | 2021 | 213 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 4549 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2015 | 795 | 0.050 |
Why?
|
| Propensity Score | 1 | 2023 | 750 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 395 | 0.040 |
Why?
|
| Patient Safety | 1 | 2015 | 649 | 0.040 |
Why?
|
| Postnatal Care | 1 | 2019 | 47 | 0.040 |
Why?
|
| Head and Neck Neoplasms | 1 | 2015 | 3976 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2019 | 124 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2019 | 168 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2023 | 644 | 0.040 |
Why?
|
| Intestines | 1 | 2023 | 686 | 0.040 |
Why?
|
| Hyperoxia | 1 | 2000 | 133 | 0.040 |
Why?
|
| Liver | 2 | 2019 | 2961 | 0.040 |
Why?
|
| Hospitalization | 2 | 2023 | 2083 | 0.040 |
Why?
|
| Organ Size | 1 | 2019 | 690 | 0.040 |
Why?
|
| Fetus | 1 | 2021 | 601 | 0.040 |
Why?
|
| Postpartum Period | 1 | 2019 | 259 | 0.040 |
Why?
|
| Emergency Medical Services | 1 | 2002 | 429 | 0.040 |
Why?
|
| Sirolimus | 1 | 2021 | 814 | 0.040 |
Why?
|
| Intracranial Hemorrhages | 1 | 2018 | 121 | 0.040 |
Why?
|
| Laryngoscopes | 1 | 2018 | 86 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 4971 | 0.040 |
Why?
|
| Adult | 5 | 2017 | 77950 | 0.040 |
Why?
|
| Endoscopy | 1 | 2019 | 479 | 0.030 |
Why?
|
| Manikins | 1 | 2017 | 137 | 0.030 |
Why?
|
| Epithelium | 1 | 2018 | 720 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 460 | 0.030 |
Why?
|
| Decision Making | 1 | 2003 | 1287 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2000 | 987 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 50 | 0.030 |
Why?
|
| Video Recording | 1 | 2017 | 267 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 4367 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2022 | 12873 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2018 | 292 | 0.030 |
Why?
|
| Religion and Medicine | 1 | 1994 | 50 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2000 | 1129 | 0.030 |
Why?
|
| Lypressin | 1 | 2013 | 11 | 0.030 |
Why?
|
| Recurrence | 1 | 2021 | 4758 | 0.030 |
Why?
|
| Teratoma | 1 | 2015 | 236 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2018 | 773 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 4314 | 0.030 |
Why?
|
| Risk Factors | 2 | 2007 | 17523 | 0.030 |
Why?
|
| Partial Pressure | 1 | 2012 | 39 | 0.030 |
Why?
|
| Tracheostomy | 1 | 2015 | 243 | 0.030 |
Why?
|
| Adolescent | 3 | 2018 | 31252 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2015 | 643 | 0.030 |
Why?
|
| Diaphragmatic Eventration | 1 | 2011 | 8 | 0.030 |
Why?
|
| Asphyxia Neonatorum | 1 | 1991 | 15 | 0.030 |
Why?
|
| Vena Cava, Superior | 1 | 2012 | 78 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2015 | 592 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 2292 | 0.020 |
Why?
|
| Anal Canal | 1 | 2012 | 238 | 0.020 |
Why?
|
| Patient Selection | 1 | 2019 | 2055 | 0.020 |
Why?
|
| Intensive Care, Neonatal | 1 | 1991 | 53 | 0.020 |
Why?
|
| Spine | 1 | 2012 | 293 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 2012 | 313 | 0.020 |
Why?
|
| Catheter-Related Infections | 1 | 2014 | 270 | 0.020 |
Why?
|
| Vena Cava, Inferior | 1 | 2012 | 190 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 14889 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 2594 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2011 | 317 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2011 | 254 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2011 | 327 | 0.020 |
Why?
|
| Heart Atria | 1 | 2012 | 352 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2011 | 402 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 644 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2017 | 1270 | 0.020 |
Why?
|
| Age Factors | 1 | 2018 | 5377 | 0.020 |
Why?
|
| Esophagus | 1 | 2012 | 553 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1994 | 2927 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2011 | 691 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2018 | 5710 | 0.020 |
Why?
|
| Equipment Design | 1 | 2012 | 1204 | 0.020 |
Why?
|
| Palivizumab | 1 | 2008 | 64 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2011 | 641 | 0.020 |
Why?
|
| Incidence | 1 | 2018 | 5673 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 1084 | 0.020 |
Why?
|
| Body Weight | 1 | 2012 | 1293 | 0.020 |
Why?
|
| Logistic Models | 1 | 2014 | 3441 | 0.020 |
Why?
|
| Chromosome Banding | 1 | 2007 | 256 | 0.020 |
Why?
|
| Radiography | 1 | 2011 | 1904 | 0.020 |
Why?
|
| Pleurisy | 1 | 2006 | 11 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2007 | 172 | 0.020 |
Why?
|
| Animals | 2 | 2018 | 59536 | 0.020 |
Why?
|
| Laryngeal Diseases | 1 | 2006 | 49 | 0.020 |
Why?
|
| Alleles | 1 | 2012 | 2437 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2007 | 179 | 0.020 |
Why?
|
| Fetal Macrosomia | 1 | 2005 | 23 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6207 | 0.020 |
Why?
|
| Mutation | 2 | 2018 | 15179 | 0.020 |
Why?
|
| Electric Countershock | 1 | 2005 | 71 | 0.020 |
Why?
|
| Pneumothorax | 1 | 2006 | 153 | 0.020 |
Why?
|
| Laparotomy | 1 | 2005 | 211 | 0.010 |
Why?
|
| Bias | 1 | 2004 | 205 | 0.010 |
Why?
|
| Kidney | 1 | 2012 | 2146 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2018 | 5542 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2005 | 1145 | 0.010 |
Why?
|
| Glucose | 1 | 2005 | 1248 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2007 | 1589 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 21445 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 4821 | 0.010 |
Why?
|
| Stroke | 1 | 2006 | 1144 | 0.010 |
Why?
|
| Mice | 1 | 2018 | 34495 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2008 | 3251 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2011 | 5270 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 4938 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 5159 | 0.010 |
Why?
|
| Heart Failure | 1 | 2006 | 2516 | 0.010 |
Why?
|
| Apgar Score | 1 | 1991 | 55 | 0.010 |
Why?
|
| India | 1 | 1991 | 301 | 0.010 |
Why?
|
| United States | 1 | 2004 | 15433 | 0.000 |
Why?
|